Eric Dane believed doctors had finally found an explanation for his worsening muscle weakness. After months of medical appointments and tests, the actor received a diagnosis of a rare autoimmune disorder that he recalled being told had a treatment with a 90% effectiveness rate. But when his condition failed to improve, his doctors began considering a far more devastating possibility.

In his posthumously released memoir, My Book of Days: A Memoir in Moments, published on 3 November, the late Grey's Anatomy and Euphoria star detailed the nine-month medical journey that preceded his amyotrophic lateral sclerosis (ALS) diagnosis.

Dane first noticed something was wrong when the fingers on his right hand became numb. Initially dismissing it as 'some kind of weird nerve thing', he became more concerned when the problem returned several weeks later.

'I can't grip the chopsticks at all,' he recalled, describing an episode that prompted him to seek medical attention.

His search for answers involved several specialists. A hand specialist referred him to another doctor, who eventually sent him to a neurologist. After undergoing numerous investigations, including electromyography (EMG), Dane was given a diagnosis of multifocal motor neuropathy (MMN).

He described the condition as a 'rare autoimmune disorder causing extreme muscle weakness' and recalled being told that its treatment was '90 percent effective'.

However, the anticipated improvement never came.

Why Doctors Initially Suspected a Treatable Nerve Disorder

Multifocal motor neuropathy (MMN) is an uncommon immune-mediated condition affecting the motor nerves responsible for controlling voluntary muscle movement.

It typically causes slowly progressive, often asymmetrical muscle weakness, particularly in the hands and arms, making everyday activities such as gripping objects, writing and lifting items increasingly difficult. Unlike many other peripheral nerve disorders, MMN generally does not cause significant sensory symptoms.

Unlike ALS, MMN is potentially treatable. Intravenous immunoglobulin (IVIG) is the first-line treatment for patients with sufficiently severe symptoms and can improve muscle strength, although patients may require repeated treatments to maintain the benefits.

Dane recalled that his doctors became concerned when he failed to respond to treatment. His primary care physician eventually told him: 'We've been discussing ALS. But we have to wait and see.'

The possibility prompted further investigations, including a lumbar puncture to examine his cerebrospinal fluid and brain scans.

What Is ALS and Why Can Diagnosis Take Time?

ALS is a progressive neurological disease that damages motor neurons, the nerve cells responsible for controlling voluntary muscle movement. As these cells deteriorate, the brain increasingly loses its ability to communicate with muscles.

Early symptoms can include muscle weakness, twitching, cramps, difficulty walking, dropping objects, and changes in speech. Some patients initially experience problems in their hands or arms, while others develop symptoms in their legs or difficulties with speaking and swallowing.

Because these symptoms can overlap with those of other neurological conditions, diagnosing ALS requires clinical assessments and investigations to identify signs of motor neuron degeneration and exclude other conditions that may cause similar symptoms.

There is currently no cure for ALS. However, treatments such as riluzole can modestly slow disease progression, while multidisciplinary care, physiotherapy, nutritional support and respiratory assistance can help manage symptoms and maintain quality of life.

Eric Dane's Devastating Reaction to His Diagnosis

After nine months of investigations, Dane received confirmation in 2024 that he had ALS.

'I know I'm facing a death sentence,' he wrote in his memoir. 'My life has become a horror movie.'

He subsequently informed his estranged wife, Rebecca Gayheart, describing the emotional impact of telling her that the diagnosis was what they had feared. He recalled experiencing 'a violent impact, like getting the wind knocked out' of him.

Dane publicly revealed his diagnosis in April 2025. He died in February 2026, aged 53, leaving behind his daughters, Billie and Georgia.

His account offers a deeply personal illustration of the uncertainty that can accompany neurological symptoms, particularly when an initially treatable explanation gives way to a progressive, life-limiting disease.